Recap: Seres Therapeutics Q1 Earnings

Seres Therapeutics MCRB reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Seres Therapeutics missed estimated earnings by 17.31%, reporting an EPS of $-0.61 versus an estimate of $-0.52.

Revenue was down $4.22 million from the same period last year.

Last quarter the company missed on EPS by $0.11 which was followed by a 0.34% increase in the share price the next day.

Here's a look at Seres Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.44	-0.46	-0.37	-0.31
EPS Actual	-0.55	0.72	-0.53	-0.39
Revenue Estimate	12.25M	7.32M	5.34M	6.45M
Revenue Actual	7.22M	126.72M	5.26M	5.72M

To track all earnings releases for Seres Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar